Abstract: The present invention provides a pharmaceutical composition for prevention or treatment of a stress disease and depression, the pharmaceutical composition be safely useable without toxicity and side effects by using an extract of leaves of Vaccinium bracteatum Thunb., which is natural resource of Korea, so that the reduction of manufacturing and production costs and the import substitution and export effects can be expected through the replacement of a raw material for preparation with a plant inhabiting in nature.

Abstract: Disclosed are a medical multilayer film and use thereof. More specifically, disclosed are a medical multilayer film including: an outer layer comprising a propylene polymer selected from the group consisting of a polypropylene, a propylene copolymer and a combination thereof, an intermediate layer comprising 10 to 60% by weight of a propylene polymer selected from the group consisting of a polypropylene, a propylene copolymer and a combination thereof and 40 to 90% by weight of a thermoplastic elastomer, and an inner layer comprising 60 to 80% by weight of a propylene polymer selected from the group consisting of a polypropylene, a propylene copolymer and a combination thereof, 10 to 30% by weight of polyethylene, and 1 to 10% by weight of a thermoplastic elastomer, and use thereof.

Abstract: Provided is a compound having a spiro chiral carbon backbone, a stereoisomer thereof, an enantiomer thereof, an in vivo hydrolysable precursor thereof, or a pharmaceutically acceptable salt thereof. The compound having the spiro chiral carbon backbone has excellent osteoblast differentiation activity, mast cell inhibitory activity, and fatty acid synthesis inhibitory activity in the liver. Therefore, the compound can be expected to play an innovative role in treatment of osteoporosis, fatty liver, and obesity.

Abstract: Disclosed are a medical multilayer film and use thereof. More specifically, disclosed are a medical multilayer film including: an outer layer comprising a propylene polymer selected from the group consisting of a polypropylene, a propylene copolymer and a combination thereof, an intermediate layer comprising 10 to 60% by weight of a propylene polymer selected from the group consisting of a polypropylene, a propylene copolymer and a combination thereof and 40 to 90% by weight of a thermoplastic elastomer, and an inner layer comprising 60 to 80% by weight of a propylene polymer selected from the group consisting of a polypropylene, a propylene copolymer and a combination thereof, 10 to 30% by weight of polyethylene, and 1 to 10% by weight of a thermoplastic elastomer, and use thereof.

Abstract: Provided are a novel compound with a spiro chiral carbon backbone, a stereoisomer thereof, an enantiomer thereof, an in vivo hydrolysable precursor thereof, or a pharmaceutically acceptable salt thereof. The novel compound with the spiro chiral carbon backbone has excellent osteoblast differentiation activity, mast cell inhibitory activity, and fatty acid synthesis inhibitory activity in the liver. Therefore, the novel compound can be expected to play an innovative role in treatment of osteoporosis, fatty liver, and obesity.